Sinphar Pharmaceutical Co Ltd banner

Sinphar Pharmaceutical Co Ltd
TWSE:1734

Watchlist Manager
Sinphar Pharmaceutical Co Ltd Logo
Sinphar Pharmaceutical Co Ltd
TWSE:1734
Watchlist
Price: 30.75 TWD 0.16%
Market Cap: NT$5.8B

Sinphar Pharmaceutical Co Ltd
Investor Relations

Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, therapeutic drugs, medicated cosmetics, nutriment, health care foods, and cleaning liquid. The company is headquartered in Dongshan, Yilan. The company went IPO on 2000-10-17. The firm is also engaged in the sales of functional food products. The Company’s principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The firm mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.

Show more
Loading
1734
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Zhiwen Li
Founder & Chairman
No Bio Available
Chih-Hsiao Chen
Assistant GM, CFO & Spokesperson
No Bio Available

Contacts

Address
YILAN
DONGSHAN
No.84, Chung Shan Road, Chung Shan Village
Contacts
+88639581101
www.sinphar.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett